대한방사성의약품학회
ACADEMIC JOURNAL

On-line Submission

ɻ



 

ȣ

ȣ

111

4A1C54

Considerations and Factors for Developing New Radiopharmaceuticals

07-07 20:21

簡(acceptance)

110

13EEBC

Study on production process of graphite for biological applications of 14C-accelerator mass spectrometry

07-07 14:37

簡(acceptance)

109

CA8348

Considerations and Factors for Developing New Radiopharmaceuticals

06-19 14:57

簡(acceptance)

108

71769E

Review of the Chemistry of First-generation Tau PET Tracers

06-15 14:16

簡(acceptance)

107

2B8DDF

Study on production process of graphite for biological applications of 14C-accelerator mass spectrometry

06-11 16:31

簡(acceptance)

106

4CD26F

Radiolabeled single-domain antibody for tumor receptor imaging

06-09 17:47

簡(acceptance)

105

CD6308

Pretargeting: A concept refraining traditional flaws in tumor targeting

06-01 20:57

簡(acceptance)

104

8CF486

Synthesis and in vitro evaluation of 99mTc-labeled tetraiodothyroacetic acid for tumor angiogenesis imaging

05-19 18:14

簡(acceptance)

103

2A9C2C

Consideration of the benefits of using a high current accelerator in BNCT

05-18 13:58

簡(acceptance)

102

D37337

Comparative Study of 2-Nitroimidazole-Fluorophore-Conjugated Derivatives with Pimonidazole for Imaging Tumor Hypoxia

12-30 17:43

簡(acceptance)

101

D9681D

Revision) Effect of PEG chain additive on 6,8-dichloro-2-phenylimidazo[1,2-a]pyridineacetamide (CB185) as a TSPO-binding ligand

12-30 14:10

簡(acceptance)

100

B04D95

Facile radiolabeling of antibody-mimetic protein with In-111 via an inverse-electron-demand Diels-Alder reaction

12-26 19:05

簡(acceptance)

99

80931A

Revision)Development of radiotracer for polo-box domain of polo-like kinase 1

12-26 13:44

簡(acceptance)

98

204C3F

Revision 1) Terahertz (THz) imaging technology for therapeutic and diagnostic applications of cancer incorporating with radiopharmaceutical fields

12-26 11:36

簡(acceptance)

97

E5770B

Synthesis of 18F-labelled amino acid derivatives and biological evaluation

12-24 08:26

(rejection)

 

 1  2  3  4  5  6  7  8  9  10  11  12  13  14